Combinatorial gene targeting hTERT and BI‑1 in CNE‑2 nasopharyngeal carcinoma cell line

Liang,Yan; Li,Xiangyong; Lin,Rongwen; Zhang,Xin; Wang,Huimin; Tan,Ning; Li,Keshen; Tang,Xudong; Zhou,Keyuan; Li,Tao

doi:10.3892/br.2012.39

Combinatorial gene targeting hTERT and BI‑1 in CNE‑2 nasopharyngeal carcinoma cell line

Authors:
- Yan Liang
- Xiangyong Li
- Rongwen Lin
- Xin Zhang
- Huimin Wang
- Ning Tan
- Keshen Li
- Xudong Tang
- Keyuan Zhou
- Tao Li
View Affiliations

Affiliations: Key Laboratory for Medical Molecular Diagnostics of Guangdong Province, Guangdong Medical College, Dongguan, Guangdong 523808, P.R. China
Published online on: November 9, 2012 https://doi.org/10.3892/br.2012.39
Pages: 285-293

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nasopharyngeal carcinoma (NPC) is a common malignant tumor. In recent studies, we demonstrated that overexpression of the Bax inhibitor‑1 (BI‑1) induces cell transformation in NIH3T3 cells and that knockdown of BI‑1 and human telomerase reverse transcriptase (hTERT) gene expression suppresses NPC cell proliferation and induces apoptosis. To evaluate the combination anti‑tumor effects of siRNAs against hTERT and BI‑1 in the CNE‑2 NPC cell line, combined and separate short‑hairpin (sh)RNA plasmids targeting hTERT and BI‑1, respectively, were constructed. hTERT and BI‑1 mRNA and protein levels were examined by real‑time polymerase chain reaction (PCR) and western blot analysis. Cell proliferation, colony formation and migration ability were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), soft agar and wound healing assay. Cell apoptosis was observed by flow cytometry, Hoechst 33258 staining and caspase‑3 activity. hTERT, BI‑1 and combined shRNA plasmids were injected into xenograft NPC tumor tissues, and expression of hTERT and BI‑1 was detected by real‑time PCR and immunohistochemistry. Tumor growth was measured by tumor volume and apoptosis in vivo was confirmed by TdT‑mediated dUTP nick end‑labeling (TUNEL). Our results showed that combined shRNA specific for hTERT and BI‑1 markedly suppressed hTERT and BI‑1 gene expression in vitro and in vivo. In addition, CNE‑2 cell proliferation was inhibited in vitro as well as in vivo. Following the knockdown of the two gene expressions, CNE‑2 exhibited a decrease in colony formation and migration ability and an increase in the apoptotic rate compared to the control groups. Our in vitro and in vivo study showed that the combinative silencing of the two genes enhanced the therapeutic effect compared to the silencing of each individual shRNA. These data suggested that combinatorial gene therapy targeting hTERT and BI‑1 may be beneficial as a tumor therapy strategy against human NPCs.

View Figures

View References

1	Parkin DM and Muir CS: Cancer incidence in five continents Comparability and quality of data. IARC Sci Publ. 45–173. 1992.PubMed/NCBI
2	Chou J, Lin YC, Kim J, et al: Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008. View Article : Google Scholar : PubMed/NCBI
3	Ichim TE, Li M, Qian H, et al: RNA interference: a potent tool for gene-specific therapeutics. Am J Transplant. 4:1227–1236. 2004. View Article : Google Scholar : PubMed/NCBI
4	Kaneko N, Miura K, Gu Z, et al: siRNA-mediated knockdown against CDCA1 and KNTC2, both frequently overexpressed in colorectal and gastric cancers, suppresses cell proliferation and induces apoptosis. Biochem Biophys Res Commun. 390:1235–1240. 2009. View Article : Google Scholar : PubMed/NCBI
5	Pu P, Zhang Z, Kang C, et al: Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther. 16:351–361. 2009. View Article : Google Scholar : PubMed/NCBI
6	Choudhury A, Derkow K, Daneshmanesh AH, et al: Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells. Br J Haematol. 151:327–335. 2010. View Article : Google Scholar : PubMed/NCBI
7	Li Y, Li M, Yao G, et al: Telomerase inhibition strategies by siRNAs against either hTR or hTERT in oral squamous cell carcinoma. Cancer Gene Ther. 18:318–325. 2011. View Article : Google Scholar : PubMed/NCBI
8	Kraemer K, Fuessel S, Schmidt U, et al: Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin Cancer Res. 9:3794–3800. 2003.
9	Zhang PH, Zou L and Tu ZG: RNAi-hTERT inhibition hepatocellular carcinoma cell proliferation via decreasing telomerase activity. J Surg Res. 131:143–149. 2006. View Article : Google Scholar : PubMed/NCBI
10	Liu X, Huang H, Wang J, et al: Dendrimers-delivered short hairpin RNA targeting hTERT inhibits oral cancer cell growth in vitro and in vivo. Biochem Pharmacol. 82:17–23. 2011. View Article : Google Scholar : PubMed/NCBI
11	Wang Y, Duan HG, Chen SM, Xiao BK, Cheng J and Tao ZZ: Effect of RNA interference targeting human telomerase reverse transcriptase on telomerase and its related protein expression in nasopharyngeal carcinoma cells. J Laryngol Otol. 121:476–482. 2007. View Article : Google Scholar
12	Xu C, Bailly-Maitre B and Reed JC: Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 115:2656–2664. 2005. View Article : Google Scholar : PubMed/NCBI
13	Reimers K, Choi CY, Bucan V and Vogt PM: The Bax Inhibitor-1 (BI-1) family in apoptosis and tumorigenesis. Curr Mol Med. 8:148–156. 2008. View Article : Google Scholar : PubMed/NCBI
14	Robinson KS, Clements A, Williams AC, Berger CN and Frankel G: Bax Inhibitor 1 in apoptosis and disease. Oncogene. 30:2391–2400. 2011. View Article : Google Scholar : PubMed/NCBI
15	Xiang-yong L, Yang-chao C, Ke-yuan Z, Mei-hong Z, Hai-qing L, Hsiang-fu K and Xin Z: Overexpression of Bax inhibitor-1 (BI-1) induces cell transformation in NIH3T3 cells. Cell Biol Int. 34:1099–1104. 2010. View Article : Google Scholar : PubMed/NCBI
16	Zhang M, Li X, Zhang Y and Zhou K: Bax inhibitor-1 mediates apoptosis-resistance in human nasopharyngeal carcinoma cells. Mol Cell Biochem. 333:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
17	Li XY, Lai YK, Zhang JF, et al: Lentivirus-mediated RNA interference targeting Bax inhibitor-1 suppresses ex vivo cell proliferation and in vivo tumor growth of nasopharyngeal carcinoma. Hum Gene Ther. 22:1201–1208. 2011. View Article : Google Scholar : PubMed/NCBI
18	Sizhong Z, Xiukung G and Yi Z: Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma. Int J Cancer. 31:587–590. 1983. View Article : Google Scholar : PubMed/NCBI
19	Chan AT: Nasopharyngeal carcinoma. Ann Oncol. 21(Suppl 7): 308–312. 2010.
20	Shammas MA, Koley H, Batchu RB, et al: Telomerase inhibition by siRNA causes senescence and apoptosis in Barrett’s adenocarcinoma cells: mechanism and therapeutic potential. Mol Cancer. 4:242005.PubMed/NCBI
21	de Souza Nascimento P, Alves G and Fiedler W: Telomerase inhibition by an siRNA directed against hTERT leads to telomere attrition in HT29 cells. Oncol Rep. 16:423–428. 2006.PubMed/NCBI
22	Zhong YQ, Xia ZS, Fu YR and Zhu ZH: Knockdown of hTERT by SiRNA suppresses growth of Capan-2 human pancreatic cancer cell via the inhibition of expressions of Bcl-2 and COX-2. J Dig Dis. 11:176–184. 2010. View Article : Google Scholar : PubMed/NCBI
23	Kunze D, Wuttig D, Fuessel S, et al: Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells. Anticancer Res. 28:2259–2263. 2008.PubMed/NCBI
24	Song Y, Dong MM and Yang HF: Effects of RNA interference targeting four different genes on the growth and proliferation of nasopharyngeal carcinoma CNE-2Z cells. Cancer Gene Ther. 18:297–304. 2011. View Article : Google Scholar
25	Zhou H, Xia XG and Xu Z: An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi. Nucleic Acids Res. 33:e622005. View Article : Google Scholar